跳至主要内容
临床试验/EUCTR2008-008936-10-DE
EUCTR2008-008936-10-DE进行中(未招募)不适用

Comparative evaluation of different CMR pulse-sequences with respect to their practicability and diagnostic performance in diagnosing the inflamed myocardium in patients with acute myocardial infarction based on the detection of macrophages in the infarcted myocardium using Resovist® and FerahemeTM

Division of Cardiology, Robert-Bosch-Krankenhaus0 个研究点开始时间: 2009年1月12日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - acute STEMI or NSTEMI (minimally 2d to maximally 7d before the scheduled CMR imaging)
  • - age >18 yrs
  • - coronary artery disease
  • - myocardial infarction detected by contrast-imaging with gadolinium-based compounds
  • - ability to give written consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - contraindications to magnetic resonance imaging
  • - contraindications to Resovist/Feraheme
  • - asthma / allergic predisposition

研究者

发起方
Division of Cardiology, Robert-Bosch-Krankenhaus

相似试验